Aims-To study the immunohistochemical expression of carcinoembryonic antigen (CEA) in ductal hyperplasia of the breast and to investigate its putative relation with atypia and co-existing infiltrating ductal carcinoma. Methods-Paraffin wax embedded tissue from 37 cases of isolated ductal hyperplasia (five with atypia and 32 without atypia) and 25 cases of ductal hyperplasia associated infiltrating ductal carcinoma (IDC) (seven with atypia and 18 without atypia) was stained with a monoclonal anti-CEA antibody using a standard avidin biotin immunoperoxidase method. Results-CEA immunoreactivity was observed in eight (12x8%) Pathol 1995;48:53-56) 
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Abstract Aims-To study the immunohistochemical expression of carcinoembryonic antigen (CEA) in ductal hyperplasia of the breast and to investigate its putative relation with atypia and co-existing infiltrating ductal carcinoma. Methods-Paraffin wax embedded tissue from 37 cases of isolated ductal hyperplasia (five with atypia and 32 without atypia) and 25 cases of ductal hyperplasia associated infiltrating ductal carcinoma (IDC) (seven with atypia and 18 without atypia) was stained with a monoclonal anti-CEA antibody using a standard avidin biotin immunoperoxidase method. Results-CEA immunoreactivity was observed in eight (12x8%) ductal hyperplasia cases. The percentage of CEA positivity in ductal hyperplasia cases with atypia (33.3%) was substantially higher than that observed in cases of ductal hyperplasia without atypia (8x0%). Six cases of ductal hyperplasia associated IDC reacted with CEA; in these six cases the neoplastic celis of the co-existing carcinoma were also CEA positive. The percentage of CEA immunoreactivity in ductal hyperplasia associated IDC was higher than that observed in isolated ductal hyperplasia (24.0 v Sections of colonic adenocarcinoma were always positive for CEA, while omission of primary antisera resulted in the complete loss of immunoreactivity.
Results
The results are summarised in table 1. The mean age of those patients with isolated ductal hyperplasia was 40 years (range 17-60 years) and of those with ductal hyperplasia associated IDC was 54 years (range 31-75 years). The percentage of atypia in cases of isolated ductal hyperplasia was similar to that in cases of ductal hyperplasia associated IDC (21 6 v 28&0%).
CEA immunoreactivity was observed in eight (12.8%) cases of ductal hyperplasia. The hyperplastic cells showed strong cytoplasmatic positivity (fig 1) . Myoepithelial cells were consistently CEA negative. The percentage of CEA positivity in cases of ductal hyperplasia with atypia (33 3%) was significantly higher (p < 0 05) than that in those without atypia (8 
0%).
Six ductal hyperplasia associated IDC cases were positive for CEA (table 1). In these six cases the neoplastic cells of the co-existing carcinoma were also CEA positive. CEA immunoreactivity was observed in 10 Polymorphonuclear leucocytes in breast epithelial tissue sections were always negative for CEA, excluding a putative cross-reaction with non-specific cross-reacting antigen.
Discussion
The major concern when using CEA as a putative marker of malignant transformation is to choose an antibody with appropriate specificity and sensitivity, '7 (table 2) .
In material obtained using fine needle aspiration Kandaraki et al'6 reported a high frequency of CEA immunoreactivity in benign breast lesions (42-1%), but these authors did not classify the lesions studied in their series. Our data, showing CEA immunoreactivity in 5*4% cases of isolated ductal hyperplasia, support the hypothesis that CEA positivity is not restricted to malignant cells in the breast. As CEA expression is not restricted to malignant cells in other tissues,2' 22 it is not surprising that some cases of benign breast disease are CEA positive.
Papotti et a124 and Kuhajda et al '5 observed CEA positive staining in papillomas (table 2) . Furthermore, Papotti et a!24 suggested that the progression from multiple intraductal papillomas to breast cancer was related to CEA expression. Lee et a1'8 observed CEA positivity in atypical ductal hyperplasia associated IDC without mentioning the frequency of this observation. In the present study we observed three distinct levels of CEA immunoreactivity: 3 1 % in isolated, non-atypical ductal hyperplasia; 16-7 and 200%, respectively, in non-atypical ductal hyperplasia associated IDC and isolated atypical ductal hyperplasia; and 42-9% in atypical ductal hyperplasia associated IDC. The important 
